Posted:
8/28/2024, 2:03:54 PM
Location(s):
Seoul, South Korea
Experience Level(s):
Senior
Field(s):
Finance & Banking
ROLE SUMMARY:
(Sr.) Pricing & Reimbursement Specialist is responsible for managing and conducting assigned assets’ pricing & reimbursement for the launch and life-cycle management under significant supervision in a structured environment.
ROLE RESPONSIBILITIES:
Leads Access strategy development for new products pricing & reimbursement
Develops P&R strategy for HIRA and negotiation strategy for NHIS in collaboration with a cross-functional team
Develops Pharmacoeconomics strategy for economic value proposition (if necessary)
Develops product value dossier with relevant clinical and economic data
Stakeholders Communication: Negotiates with government decision bodies including MOHW, HIRA and NHIS
Maximizes business opportunity in collaboration with Business Unit
Leads reimbursement expansion for in-line product
Provides access expertise to Business Unit regarding access issues
Brings into access team operations
Provides single point of contact for assigned Business Unit
Takes lead on regular communication (e.g. H&V Update Meeting) with Business Unit in collaboration
Communicates with Global Health & Value including PSP (Price Strategy Proposal)
Manages price information through JADE
Supports industrial collaboration to shape the environment for patient access
QUALIFICATIONS:
Above Bachelor's degree, preferably in pharmacy, nursing or business
General understanding of pharmaceutical industry, healthcare policy, pricing and reimbursement system, HTA, and pricing decision-making process
Fluency in English and Korean (both verbal and writing skills)
Application Deadline: August 12 (Fri), 2022 6:00 pm
Please apply via Pfizer Career Website Only.
#LI-PFE
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Market Access#LI-PFEWebsite: https://www.pfizer.com/
Headquarter Location: New York, New York, United States
Employee Count: 10001+
Year Founded: 1849
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine